Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsutomu Takeuchi

Showing results (11-20 of 785) with videos related to

Pageof 79
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 28, 2009
[Present status and problems in biologics for treatment of rheumatoid arthritis in Japan]Tsutomu Takeuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 25, 2012
[The 39th scientific meeting: perspectives of internal medicine; the cutting edge of treatment of medical disorders encountered in clinical practice; 9. Progress in RA management]Tsutomu Takeuchi
Clinical Immunology (Orlando, Fla.)|July 25, 2017
Biomarkers as a treatment guide in rheumatoid arthritisTsutomu Takeuchi
Clinical Calcium|June 29, 2012
[Achievement in therapy for rheumatoid arthritis without dysfunctional sequela]Tsutomu Takeuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 20, 2011
[Treatment of rheumatic diseases: current status and future prospective. Editorial: Treatment of collagen-vascular diseases: current status and future perspective]Tsutomu Takeuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 13, 2009
[Indications for and use of biologics in early rheumatoid arthritis based on the evidence]Tsutomu Takeuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 17, 2005
[Biological agents targeting on pro-inflammatory cytokines]Tsutomu Takeuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 11, 2012
[Rheumatoid arthritis: progress in diagnosis and treatment editorial: progress in diagnosis and treatment of rheumatoid arthritis]Tsutomu Takeuchi
Modern Rheumatology|May 15, 2023
Structural, nonclinical, and clinical features of ozoralizumab: A novel tumour necrosis factor inhibitorTsutomu Takeuchi
Internal Medicine (Tokyo, Japan)|August 21, 2007
Treatment of inflammatory immunologic disease 3. Anti-TNF therapy in rheumatoid arthritisTsutomu Takeuchi
Pageof 79

Showing results (11-20 of 785) with videos related to

Sort By:
Pageof 79
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 28, 2009
[Present status and problems in biologics for treatment of rheumatoid arthritis in Japan]Tsutomu Takeuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 25, 2012
[The 39th scientific meeting: perspectives of internal medicine; the cutting edge of treatment of medical disorders encountered in clinical practice; 9. Progress in RA management]Tsutomu Takeuchi
Clinical Immunology (Orlando, Fla.)|July 25, 2017
Biomarkers as a treatment guide in rheumatoid arthritisTsutomu Takeuchi
Clinical Calcium|June 29, 2012
[Achievement in therapy for rheumatoid arthritis without dysfunctional sequela]Tsutomu Takeuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 20, 2011
[Treatment of rheumatic diseases: current status and future prospective. Editorial: Treatment of collagen-vascular diseases: current status and future perspective]Tsutomu Takeuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 13, 2009
[Indications for and use of biologics in early rheumatoid arthritis based on the evidence]Tsutomu Takeuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 17, 2005
[Biological agents targeting on pro-inflammatory cytokines]Tsutomu Takeuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 11, 2012
[Rheumatoid arthritis: progress in diagnosis and treatment editorial: progress in diagnosis and treatment of rheumatoid arthritis]Tsutomu Takeuchi
Modern Rheumatology|May 15, 2023
Structural, nonclinical, and clinical features of ozoralizumab: A novel tumour necrosis factor inhibitorTsutomu Takeuchi
Internal Medicine (Tokyo, Japan)|August 21, 2007
Treatment of inflammatory immunologic disease 3. Anti-TNF therapy in rheumatoid arthritisTsutomu Takeuchi
Pageof 79